IFP Advisors, Inc - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,528
-77.4%
1,735
-50.0%
0.00%
Q2 2023$20,074
+44.8%
3,470
+100.0%
0.00%
-100.0%
Q1 2023$13,863
+98921.4%
1,7350.0%0.00%
Q4 2022$14
-99.9%
1,7350.0%0.00%
Q3 2022$14,0000.0%1,7350.0%0.00%
Q2 2022$14,000
-50.0%
1,735
-50.0%
0.00%
Q1 2022$28,000
+16.7%
3,470
+100.0%
0.00%
Q4 2021$24,000
-36.8%
1,7350.0%0.00%
-100.0%
Q3 2021$38,000
+90.0%
1,735
+15.7%
0.00%
Q2 2021$20,0001,5000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders